REQUEST A DEMO
Total
USD $0.00
Search more companies

B-Crobes Laboratory Sdn. Bhd. (Malaysia)

Main Activities: Pharmacies and Drug Stores
Full name: B-Crobes Laboratory Sdn. Bhd. Profile Updated: February 05, 2024
Buy our report for this company USD 29.95 Most recent financial data: 2022 Available in: English Download a sample report

B-Crobes Laboratory Sdn. Bhd is a healthcare company founded by CEO Dean Lee. The company focuses on providing healthcare products, with a special emphasis on replenishing important bacteria for digestive health and overall well-being. B-Crobes has developed a unique formulation called HEXBIO MCP, supported by over 20 clinical studies, and is committed to continuous innovation in the healthcare industry. The company's products are free of allergens and are aimed at alleviating gut disturbances.

Headquarters
No. 31-B Jalan Usj 10/1E
Subang Jaya; Selangor; Postal Code: 47620

Contact Details: Purchase the B-Crobes Laboratory Sdn. Bhd. report to view the information.

Website: http://www.bcrobes.com

Basic Information
Outstanding Shares:
Purchase the B-Crobes Laboratory Sdn. Bhd. report to view the information.
Registered Capital:
Purchase the B-Crobes Laboratory Sdn. Bhd. report to view the information.
Financial Auditors:
Purchase the B-Crobes Laboratory Sdn. Bhd. report to view the information.
Incorporation Date:
August 08, 2002
Key Executives
Purchase this report to view the information.
Director
Purchase this report to view the information.
Director
Purchase this report to view the information.
Director
Purchase this report to view the information.
Secretary
Ownership Details
Purchase this report to view the information.
78.35%
Purchase this report to view the information.
21.65%
Company Performance
Financial values in the chart are available after B-Crobes Laboratory Sdn. Bhd. report is purchased.
Looking for more than just a company report?

EMIS company profiles are part of a larger information service which combines company, industry and country data and analysis for over 145 emerging markets.

Request a demo of the EMIS service
Key Financial Highlights
Annual growth percentages for latest two years in local currency MYR. Absolute financial data is included in the purchased report.
Net sales revenue
69.47%
Total operating revenue
69.47%
Operating profit (EBIT)
513.98%
EBITDA
333.8%
Net Profit (Loss) for the Period
588.17%
Total assets
30.56%
Total equity
89.22%
Operating Profit Margin (ROS)
26.75%
Net Profit Margin
21.08%
Return on Equity (ROE)
34.19%
Debt to Equity Ratio
-90.53%
Quick Ratio
1.16%
Cash Ratio
1.12%

To view more information, Request a demonstration of the EMIS service

Buy this company report
Need ongoing access to company, industry or country information?